Treatment

IPN10200 Placebo clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1, PHASE2
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines
This study is testing a new medicine, IPN10200, for improving moderate to severe lines on the upper face. Researchers want to find the best dose that is both safe and works well, comparing it to an inactive treatment (placebo) and an existing treatment called Dysport.
For: Moderate to Severe Upper Facial Lines
France · Germany